Abstract

AML-664 A Tertiary Center's Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call